打它硬:优化免疫检查点抑制的患者的定性观点
Sophie Merrick1, Hannah L Rush1,2, Susanna Daniels3
1MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, 2nd Floor 90 High Holborn, London, WC1V 6LJ, UK.
British journal of cancer
|June 17, 2024
概括
患者和护理人员的观点表明,减少免疫检查点抑制剂 (ICI) 治疗计划需要仔细考虑个体的风险,益处和先前治疗信念,以确保试验的可接受性.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 临床试验 临床试验
背景情况:
- 免疫检查点抑制剂 (ICI) 彻底改变了黑色素瘤和细胞癌 (RCC) 的癌症治疗方法.
- 正在探索优化ICI治疗计划,以提高生活质量,耐受性和成本效益.
- 了解患者和护理人员的观点对于成功实施试验至关重要.
研究的目的:
- 探索患者和护理人员对随机试验的观点,评估减少ICI治疗计划.
- 确定影响参与ICI优化试验的因素.
- 为未来ICI优化试验的设计提供信息.
主要方法:
- 七个焦点小组由31名参与者组成,包括患有第四阶段黑色素瘤或RCC的患者及其照顾者.
- 用反射主题分析分析数据,以确定关键主题.
主要成果:
- 参与者重视治疗和诊所访问的保证;减少访问可能不会改善生活质量.
- 加入ICI优化试验的决定取决于治疗反应,毒性和感知到的后勤效益.
- 关于治疗的预先存在的信念,例如"更多是更好的",会影响参与试验.
结论:
- 对患者和护理人员观点的洞察力可以解决ICI优化试验中的招聘挑战.
- 建议在正在进行的和未来的ICI优化试验中使用增强招聘的策略.
- 试验设计必须对患者来说是可以接受的,以确保成功实施和结果.
相关概念视频
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Cytotoxic T Cells-mediated Immune Response
889
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
889


